Ryan Kellogg

CEO & Co-Founder at RTHM

Dr. Kellogg’s experience with complex illness led him to pioneer the technology for molecular profiling using self-collected blood microsamples. This allows for a better understanding of health fluctuations and the impacts of health interventions. When combined with wearable sensors and symptom tracking, this technology allows for real-time health monitoring and pattern discovery with unprecedented resolution.

Links

Previous companies

Stanford Medicine logo

Timeline

  • CEO & Co-Founder

    Current role

  • CEO

View in org chart